Persistence of high density lipoprotein particles in obese mice lacking apolipoprotein A-I

Journal of Lipid Research

Volumn 46, Issue 9, 2005, Pages 2007-2014

  Gruen, Marnie L ^a   Plummer, Michelle R ^a   Zhang, Wenwu ^b   Posey, Kelly A ^a   Linton, MacRae F ^a,b   Fazio, Sergio ^b   Hasty, Alyssa H ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Hepatic lipase; Obesity; Remodeling; Scavenger receptor class B type I; Small, dense low density lipoproteins

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; LEPTIN RECEPTOR; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; ENZYME ACTIVITY; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIGENS, CD36; APOLIPOPROTEIN A-I; CROSSES, GENETIC; GENE EXPRESSION; LIPASE; LIPOPROTEINS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY; PARTICLE SIZE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, SCAVENGER; RNA, MESSENGER; SCAVENGER RECEPTORS, CLASS B;

EID: 24344483109     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M500181-JLR200     Document Type: Article

References (34)

1. Silver, D. L., X. C. Jiang, T. Arai, C. Bruce, and A. R. Tall. 2000. Receptors and lipid transfer proteins in HDL metabolism. Ann. N. Y. Acad. Sci. 902: 103-111; discussion 111-112.
2. Rader, D. J., and K. Ikewaki. 1996. Unravelling high density lipoprotein-apolipoprotein metabolism in human mutants and animal models. Curr. Opin. Lipidol. 7: 117-123.
3. Acton, S., A. Rigotti, K. T. Landschulz, S. Xu, H. H. Hobbs, and M. Krieger. 1996. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science. 271: 518-520.
4. Tall, A. R., X. Jiang, Y. Luo, and D. Silver. 2000. 1999 George Lyman Duff Memorial Lecture. Lipid transfer proteins, HDL metabolism, and atherogenesis. Arterioscler. Thromb. Vasc. Biol. 20: 1185-1188.
5. Nishina, P. M., S. Lowe, J. Wang, and B. Paigen. 1994. Characterization of plasma lipids in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow. Metabolism. 43: 549-553.
6. Silver, D. L., N. Wang, and A. R. Tall. 2000. Defective HDL particle uptake in ob/ob hepatocytes causes decreased recycling, degradation, and selective lipid uptake. J Clin. Invest. 105: 151-159.
7. Nishina, P. M., J. K. Naggert, J. Verstuyft, and B. Paigen. 1994. Atherosclerosis in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow. Metabolism. 43: 554-558.
8. Silver, D. L., X-C. Jiang, and A. R. Tall. 1999. Increased high density lipoprotein (HDL), defective hepatic catabolism of apoA-I and apoA-II, and decreased apoA-I mRNA in ob/ob mice. J. Biol. Chem. 274: 4140-4146.
9. Shih, D. Q., M. Bussen, E. Sehayek, M. Ananthanarayanan, B. L. Shneider, F. J. Suchy, S. Shefer, J. S. Bollileni, F. J. Gonzalez, J. L. Breslow, et al. 2001. Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism. Nat. Genet. 27: 375-382.
10. Wolfrum, C., M. N. Poy, and M. Stoffel. 2005. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat. Med. 11: 418-422.
11. Foger, B., M. Chase, M. J. Amar, B. L. Vaisman, R. D. Shamburek, B. Paigen, J. Fruchart-Najib, J. A. Paiz, C. A. Koch, R. F. Hoyt, et al. 1999. Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice. J. Biol. Chem. 274: 36912-36920.
12. Rigotti, A., B. L. Trigatti, M. Penman, H. Rayburn, J. Herz, and M. Krieger. 1997. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc. Natl. Acad. Sci. USA. 94: 12610-12615.
13. Williamson, R., D. Lee, J. Hagaman, and N. Maeda. 1992. Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I. Proc. Natl. Acad. Sci. USA. 89:7134-7138.
14. Silver, D. L. 2002. A carboxyl-terminal PDZ-interacting domain of scavenger receptor B, type I is essential for cell surface expression in liver. J. Biol. Chem. 277: 34042-34047.
15. Carrier, J. C., G. Deblois, C. Champigny, E. Levy, and V. Giguere. 2004. Estrogen-related receptor alpha (ERRalpha) is a transcriptional regulator of apolipoprotein A-IV and controls lipid handling in the intestine. J. Biol. Chem. 279: 52052-52058.
16. Xu, N., P. Nilsson-Ehle, M. Hurtig, and B. Ahren. 2004. Both leptin and leptin-receptor are essential for apolipoprotein M expression in vivo. Biochem. Biophys. Res. Commun. 321: 916-921.
17. Memon, R. A., L. H. Tecott, K. Nonogaki, A. Beigneux, A. H. Moser, C. Grunfeld, and K. R. Feingold. 2000. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice. Endocrinology. 141: 4021-4031.
18. Ferrante, A. W., Jr., M. Thearle, T. Liao, and R. L. Leibel. 2001. Effects of leptin deficiency and short-term repletion on hepatic gene expression in genetically obese mice. Diabetes. 50: 2268-2278.
19. Lundasen, T., W. Liao, B. Angelin, and M. Rudling. 2003. Leptin induces the hepatic high density lipoprotein receptor scavenger receptor B type I (SR-BI) but not cholesterol 7alpha-hydroxylase (Cyp7a1) in leptin-deficient (ob/ob) mice. J. Biol. Chem. 278:43224-43228.
20. Homanics, G. E., H. V. de Silva, J. Osada, S. H. Zhang, H. Wong, J. Borensztajn, and N. Maeda. 1995. Mild dyslipidemia in mice following targeted inactivation of the hepatic lipase gene. J. Biol. Chem. 270: 2974-2980.
21. Brown, R. J., A. Gauthier, R. J. Parks, R. McPherson, D. L. Sparks, J. R. Schultz, and Z. Yao. 2004. Severe hypoalphalipoproteinemia in mice expressing human hepatic lipase deficient in binding to heparan sulfate proteoglycan. J. Biol. Chem. 279: 42403-42409.
22. Aouizerat, B. E., and J. P. Kane. 2003. Apolipoprotein A-II: Active or passive role in familial combined hyperlipidemia. Circ. Res. 92: 1179-1181.
23. Gordon, D. J., and B. M. Rifkind. 1989. High-density lipoprotein-the clinical implications of recent studies. N. Engl. J. Med. 321: 1311-1316.
24. Goldbourt, U., S. Yaari, and J. H. Medalie. 1997. Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men. Arterioscler. Thromb. Vasc. Biol. 17: 107-113.
25. Miyazaki, A., S. Sakuma, W. Morikawa, T. Takiue, F. Miake, T. Terano, M. Sakai, H. Hakamata, Y. Sakamoto, M. Natio, et al. 1995. Intravenous injection of rabbit apolipoprotein A-I inhibits the progression of atherosclerosis in cholesterol-fed rabbits. Arterioscler. Thromb. Vasc. Biol. 15: 1882-1888.
26. Rong, J. X., J. Li, E. D. Reis, R. P. Choudhury, H. M. Dansky, V. I. Elmalem, J. T. Fallon, J. L. Breslow, and E. A. Fisher. 2001. Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content. Circulation. 104: 2447-2452.
27. Rubin, E. M., R. M. Krauss, E. A. Spangler, J. G. Verstuyft, and S. M. Clift. 1991. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature. 353: 265-267.
28. Plump, A. S., C. J. Scott, and J. L. Breslow. 1994. Human apolipo-protein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. Proc. Natl. Acad. Sci. USA. 91: 9607-9611.
29. Paszty, C., N. Maeda, J. Verstuyft, and E. M. Rubin. 1994. Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. J. Clin. Invest. 94: 899-903.
30. Belalcazar, L. M., A. Merched, B. Carr, K. Oka, K. H. Chen, L. Pastore, A. Beaudet, and L. Chan. 2003. Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia. Circulation. 107: 2726-2732.
31. Benoit, P., F. Emmanuel, J. Caillaud, L. Bassinet, G. Castro, P. Gallix, J. Fruchart, D. Branellec, P. Denefle, and N. Duverger. 1999. Somatic gene transfer of human apoA-I inhibits atherosclerosis progression in mouse models. Circulation. 99: 105-110.
32. Tangirala, R. K., K. Tsukamoto, S. H. Chun, D. Usher, E. Pure, and D. J. Rader. 1999. Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice. Circulation. 100: 1816-1822.
33. Ishiguro, H., H. Yoshida, A. S. Major, T. Zhu, V. R. Babaev, M. F. Linton, and S. Fazio. 2001. Retrovirus-mediated expression of apolipoprotein A-I in the macrophage protects against atherosclerosis in vivo. J. Biol. Chem. 276: 36742-36748.
34. -/- mice. Arterioscler. Thromb. Vasc. Biol. 21: 1790-1795.